Brewin Dolphin LTD Myovant Sciences Ltd. Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Nov 09, 2023
SELL
$13.8 - $27.62 $31,050 - $62,145
-2,250 Closed
0 $0
Q2 2020

Nov 09, 2023
SELL
$7.34 - $20.84 $5,505 - $15,630
-750 Reduced 25.0%
2,250 $46.4 Million
Q1 2020

Nov 09, 2023
BUY
$6.55 - $14.76 $4,912 - $11,070
750 Added 33.33%
3,000 $22.7 Million
Q4 2019

Nov 09, 2023
BUY
$4.2 - $19.21 $9,450 - $43,222
2,250 New
2,250 $34.9 Million

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email